I'm thinking they win for RSV. Which will make for a fantastic press release tomorrow morning. It should also generate lots of follow up articles and maybe and upgrade or two. What do others think?
med.. you could be right. I had forgotten about this award possibility. Indeed... it could go to Novavax as it did in India for malaria. If so, Novavax darn well should issue a good, strong, well-written, pumpy release on it.
We think you are trying too hard